ArticleRenal failure2026
Smoking exposure and long-term progression of IgA nephropathy: a retrospective cohort study of 9,560 patients.
Article in Renal failure, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAlthough cigarette smoking is an exposure associated with chronic kidney disease, its role in the progression of IgA nephropathy (IgAN) remains not well defined. We investigated the association between smoking exposure and adverse kidney outcomes in a large Chinese cohort of patients with IgAN.
methodsThis retrospective cohort study included 9,560 adults with biopsy-proven IgAN at Jinling Hospital between 2007 and 2016. Cox proportional hazards models were used to assess kidney failure and a 50% decline in estimated glomerular filtration rate (eGFR). Because only 24 women reported smoking, the primary analysis was restricted to men and adjusted for age (using a restricted cubic spline), eGFR, log-transformed proteinuria, hypertension, diabetes, uric acid, and albumin.
resultsAmong 9,560 patients, 1,441 (15.1%) were current or former smokers, of whom 1,417 were men. In the 4,494 men, unadjusted hazard ratios (HRs) were 1.31 (95% confidence interval [CI], 1.13-1.51) for kidney failure and 1.26 (95% CI, 1.12-1.42) for a 50% decline in eGFR (both
conclusionsBaseline current or former smoking was associated with adverse kidney outcomes among men with IgAN. Interpretation is limited by potential residual confounding and the small number of women with smoking exposure.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.